 Of the projected 41.3 M (n=16,500) adults aged 65+, 15% (6.3 M) reported both regular sleeplessness symptoms and insomnia/SD (Figure 1 ).
 All respondents were asked if they regularly experience a list of sleep symptoms or problems.
Respondents indicating any of the following symptoms were considered to have "sleeplessness symptoms":
 Difficulty falling asleep  Waking during the night and not being able to get back to sleep  Waking up several times during the night  Waking up too early (such as before the alarm clock)  Poor quality of sleep  Survey respondents included in this analysis were those who reported both insomnia/SD and sleeplessness symptoms and were aged 65 and older. Those also indicating experiencing narcolepsy, parasomnia, sleep-disordered breathing/sleep apnea, or circadian rhythm disorder were excluded from the analysis.
 If individuals indicated using an OTC/herbal product for insomnia/SD, they were given the opportunity to specify the type of product and days using each product in the past month. Products with DPH/DOX as an active ingredient were included in the DPH/DOX analyses.
 Alcohol use and frequency was asked of all respondents.  Respondents were considered to be using an anticholinergic medication if they indicated elsewhere in the survey using an Rx that had suspected or confirmed anticholinergic properties per the Anticholinergic Cognitive Burden List developed by the Healthy Aging Brain Center.
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Analyses
 Bivariate comparisons between sexes within each age group were made using chi-square tests for categorical variables and t-tests for continuous variables.
METHODOLOGY
 Although women were more likely to use DPH/DOX, men reported using the products more frequently.
 Men in both age groups reported using DPH/DOX more mean days per month (14.  Over-the-counter (OTC) sleep aid use has not been widely studied, although it is of special concern in the elderly due to the anticholinergic properties of the primary ingredients, diphenhydramine or doxylamine (DPH/DOX).
 Anticholinergic effects include greater risk of confusion, dry mouth, and constipation. Other drugs with anticholinergic properties are prescribed for conditions common in the elderly, and the effects may stack with each drug, leading to an increased risk of cognitive impairment.
INTRODUCTION
 The older population represented in the survey was likely healthier than the general elderly population, as they were noninstitutionalized and able to use the internet to take a survey.
 Data were cross-sectional in nature, and therefore causality cannot be assumed.  These data were self-reported and therefore subject to recall bias.  Due to small sample sizes, many comparisons did not show statistical significance.  Within the patient groups examined, distribution of sleeplessness symptoms and other sleep problems varied by age group and sex, although overall women were more likely to experience more symptoms than men in both age cohorts (  Approximately half of both sexes in both age groups reported "Waking up several times during the night" (48.8%-51.7%), approximately a third reported "Waking up too early (such as before the alarm clock)" (36.2%-39.4%), and approximately a quarter reported "Poor quality of sleep" (24.3%-29.2%); none of these differences were statistically significant. No statistically significant differences were found between sexes of the same age group.
LIMITATIONS
